Beers criteria

The Beers criteria, maintained and updated by the American Geriatrics Society (AGS), is an explicit list of Potentially Inappropriate Medications (PIMs) that should generally be avoided for adults aged 65 and older. Its primary purpose is to improve medication safety by guiding clinicians away from drugs that have a high risk-to-benefit ratio in the elderly. In enterprise risk management for healthcare organizations, applying the Beers criteria is a critical operational risk control. While not an ISO standard, adherence helps organizations comply with patient safety regulations, such as those mandated by The Joint Commission in the U.S. or Taiwan's Medical Care Act. It differs from general pharmacovigilance by focusing specifically on preventing predictable, high-risk prescribing for a vulnerable population, rather than just monitoring all adverse reactions.

In enterprise risk management, healthcare providers apply the Beers criteria through a structured, technology-enabled process. 1. **System Integration**: The criteria are embedded into Electronic Health Record (EHR) and pharmacy systems to trigger real-time alerts when a PIM is prescribed for an older adult. 2. **Clinical Review Protocol**: Pharmacists are empowered to review these alerts, assess the clinical necessity, and consult with the prescribing physician to recommend safer alternatives. 3. **Performance Monitoring**: The organization tracks its PIM prescription rate as a key performance indicator (KPI) for patient safety. For example, a hospital network might aim to reduce its PIM rate by 20% annually. Achieving this can lead to a measurable reduction in adverse drug events and associated costs, lower malpractice liability premiums, and demonstrate proactive risk management to regulators and accreditation bodies.

Taiwanese healthcare enterprises face several key challenges when implementing the Beers criteria: 1. **Physician Inertia**: Established prescribing habits can be difficult to change, with some physicians viewing the criteria as overly simplistic "cookbook medicine" that doesn't account for individual patient complexity. 2. **IT Integration Costs**: Integrating the criteria into legacy EHR systems can be technically challenging and financially prohibitive for smaller hospitals and clinics. 3. **Workflow Constraints**: The high-volume, time-constrained nature of Taiwan's National Health Insurance (NHI) system often leaves clinicians with insufficient time for thorough medication reviews. **Solutions**: * To address inertia, implement peer-led educational programs and academic detailing. * To lower IT barriers, adopt cloud-based Clinical Decision Support Systems (CDSS) with API integration. * To manage workflow, empower clinical pharmacists to conduct Medication Therapy Management (MTM) for high-risk patients, creating a collaborative care model.

Winners Consulting specializes in Beers criteria for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact